Tetravalent influenza vaccine developed by Sinovac Biotech Co.
PRO-QINF-3004
Phase 3 small_molecule active
Quick answer
Tetravalent influenza vaccine developed by Sinovac Biotech Co. for Influenza is a Phase 3 program (small_molecule) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Influenza
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active